Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 43, Issue 3, Pages 1345-1356
Publisher
Oxford University Press (OUP)
Online
2015-01-12
DOI
10.1093/nar/gku1392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
- (2014) Fran Supek et al. CELL
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes
- (2014) Sharmistha Pal et al. NUCLEIC ACIDS RESEARCH
- Exon identity crisis: disease-causing mutations that disrupt the splicing code
- (2014) Timothy Sterne-Weiler et al. GENOME BIOLOGY
- Ontology-aware classification of tissue and cell-type signals in gene expression profiles across platforms and technologies
- (2013) Young-suk Lee et al. BIOINFORMATICS
- Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition
- (2013) Alika K Maunakea et al. CELL RESEARCH
- Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin
- (2013) P. Mallinjoud et al. GENOME RESEARCH
- Genome variation and personalized cancer medicine
- (2013) T. J. Hudson JOURNAL OF INTERNAL MEDICINE
- RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell Proliferation
- (2013) Elias G. Bechara et al. MOLECULAR CELL
- The Reactome pathway knowledgebase
- (2013) David Croft et al. NUCLEIC ACIDS RESEARCH
- Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma
- (2013) Brandi N. Baird et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- (2013) S. J. Furney et al. Cancer Discovery
- RNA sequencing of cancer reveals novel splicing alterations
- (2013) Jeyanthy Eswaran et al. Scientific Reports
- Isoform level expression profiles provide better cancer signatures than gene level expression profiles
- (2013) ZhongFa Zhang et al. Genome Medicine
- Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events
- (2012) J. Liu et al. GENOME RESEARCH
- RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
- (2012) J. P. Venables et al. MOLECULAR AND CELLULAR BIOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations
- (2012) Krishna R. Kalari et al. Frontiers in Oncology
- WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
- (2011) Elianna M. Amin et al. CANCER CELL
- Engagement of I-Branching -1, 6-N-Acetylglucosaminyltransferase 2 in Breast Cancer Metastasis and TGF- Signaling
- (2011) H. Zhang et al. CANCER RESEARCH
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma
- (2011) E W L Law et al. ONCOGENE
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
- (2010) M. D. Wilkerson et al. CLINICAL CANCER RESEARCH
- S100A13 is a new angiogenic marker in human melanoma
- (2010) Daniela Massi et al. MODERN PATHOLOGY
- Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway
- (2010) Kasper Thorsen et al. MOLECULAR & CELLULAR PROTEOMICS
- Global Profiling and Molecular Characterization of Alternative Splicing Events Misregulated in Lung Cancer
- (2010) C. M. Misquitta-Ali et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification of 5 novel genes methylated in breast and other epithelial cancers
- (2010) Victoria K Hill et al. Molecular Cancer
- Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
- (2010) A. Lapuk et al. MOLECULAR CANCER RESEARCH
- Regulation of Alternative Splicing by Histone Modifications
- (2010) R. F. Luco et al. SCIENCE
- RNA-Seq gene expression estimation with read mapping uncertainty
- (2009) Bo Li et al. BIOINFORMATICS
- An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
- (2009) D. Mitra et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- Multiple Alternative Splicing Markers for Ovarian Cancer
- (2008) R. Klinck et al. CANCER RESEARCH
- CD44 is of Functional Importance for Colorectal Cancer Stem Cells
- (2008) L. Du et al. CLINICAL CANCER RESEARCH
- The kinesin KIF1B acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
- (2008) S. Schlisio et al. GENES & DEVELOPMENT
- A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease
- (2008) Masahiro Yanagisawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis
- (2008) Kasper Thorsen et al. MOLECULAR & CELLULAR PROTEOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started